Rezolute (RZLT) Other Non Operating Income (2014 - 2025)
Rezolute (RZLT) reported Other Non Operating Income of -$15000.0 for Q3 2025, little changed on a YoY basis from -$15000.0 in Q3 2024, and down 150.0% sequentially from -$6000.0 in Q1 2025.
Rezolute (RZLT) Other Non Operating Income (2014 - 2025) Analysis & Trends
Rezolute (RZLT) has 11 years of Other Non Operating Income data on file, last reported at -$15000.0 in Q3 2025.
- For the quarter ending Q3 2025, Other Non Operating Income changed 0.0% year-over-year to -$15000.0; the trailing twelve-month figure through Mar 2026 stood at -$21000.0 (up 97.7% YoY), and the FY2024 full-year result was -$2.8 million, down 56900.0% from the prior year.
- Other Non Operating Income eased to -$15000.0 in Q3 2025, from -$6000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.8 million in Q1 2021 to a low of -$2.0 million in Q1 2024.
- A 5-year average of -$161555.6 and a median of -$13000.0 in 2022 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income slumped 35360.0% in 2022 and soared 133.33% in 2024, its largest moves.
- Tracing RZLT's Other Non Operating Income over 5 years: stood at -$12000.0 in 2021, then slipped by 8.33% to -$13000.0 in 2022, then tumbled by 38.46% to -$18000.0 in 2023, then soared by 133.33% to $6000.0 in 2024, then sank by 350.0% to -$15000.0 in 2025.
- Business Quant data shows RZLT's Other Non Operating Income at -$15000.0 in Q3 2025, -$6000.0 in Q1 2025, and $6000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -15,000.00 |
| Mar 31, 2025 | -6,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -900,000.00 |
| Mar 31, 2024 | -1.96 Mn |
| Dec 31, 2023 | -18,000.00 |
| Sep 30, 2023 | -14,000.00 |
| Jun 30, 2023 | 35,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -13,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | -1.76 Mn |
| Mar 31, 2022 | -12,000.00 |
| Dec 31, 2021 | -12,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 1.78 Mn |
| Jun 30, 2019 | 96.00 |
| Dec 31, 2018 | 55,000.00 |